Stay updated on Amivantamab in Gastric Cancer Clinical Trial
Sign up to get notified when there's something new on the Amivantamab in Gastric Cancer Clinical Trial page.

Latest updates to the Amivantamab in Gastric Cancer Clinical Trial page
- Check5 days agoChange DetectedThe page now shows a 403 Forbidden error, replacing the expected study content with an access-denied view. As a result, standard study details and related documents are not accessible.SummaryDifference18%

- Check12 days agoNo Change Detected
- Check19 days agoNo Change Detected
- Check26 days agoChange DetectedThe page's revision history now shows a new build version v3.6.6, replacing the previous v3.6.5.SummaryDifference0.1%

- Check48 days agoChange DetectedThe page now displays a generic error HTML indicating the record is unavailable, replacing the study content and attached documents. This prevents viewing the trial details until the issue is resolved.SummaryDifference17%

- Check62 days agoChange DetectedRevision label changed from v3.6.3 to v3.6.4, indicating a minor page update; no changes to study data, eligibility, or user-facing content are evident.SummaryDifference0.0%

- Check82 days agoChange DetectedThe site revision tag was updated from v3.6.2 to v3.6.3, indicating a new build of the ClinicalTrials.gov page.SummaryDifference0.0%

- Check89 days agoChange DetectedThe page now displays Revision: v3.6.2, replacing the previous Revision: v3.6.0. This update is a metadata release tag and does not change study data or content.SummaryDifference0.1%

Stay in the know with updates to Amivantamab in Gastric Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Amivantamab in Gastric Cancer Clinical Trial page.